Carrie Adams, PharmD, the chief quality/transformation officer at Meritus Health, in Hagerstown, Md., spoke to us about providing casirivimab and imdevimab (Regen-Cov, Regeneron) to people exposed to SARS-CoV-2. The FDA recently updated the emergency use authorization for casirivimab and imdevimab to enable it to be used as post-exposure prophylaxis. Dr. Adams, who oversees hospital and ambulatory quality and performance improvement, offers tips and insight into providing this infusion to patients.